PPBT
Price:
$2.97
Market Cap:
$5.72M
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and ...[Read more]
Industry
Biotechnology
IPO Date
2015-11-20
Stock Exchange
NASDAQ
Ticker
PPBT
According to Purple Biotech Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is -541411.00. This represents a change of -100.15% compared to the average of 349.99M of the last 4 quarters.
The mean historical Enterprise Value of Purple Biotech Ltd. over the last ten years is 4.31B. The current -541411.00 Enterprise Value has changed -101.26% with respect to the historical average. Over the past ten years (40 quarters), PPBT's Enterprise Value was at its highest in in the June 2020 quarter at 13.28B. The Enterprise Value was at its lowest in in the March 2015 quarter at 18.36M.
Average
4.31B
Median
1.97B
Minimum
13.28M
Maximum
12.30B
Discovering the peaks and valleys of Purple Biotech Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 92.56%
Maximum Annual Enterprise Value = 12.30B
Minimum Annual Increase = -88.43%
Minimum Annual Enterprise Value = 13.28M
Year | Enterprise Value | Change |
---|---|---|
2023 | 3.40B | 585.39% |
2022 | 495.57M | -63.95% |
2021 | 1.37B | 5.66% |
2020 | 1.30B | 336.88% |
2019 | 297.82M | -88.43% |
2018 | 2.57B | -72.08% |
2017 | 9.22B | -24.11% |
2016 | 12.15B | -1.24% |
2015 | 12.30B | 92.56% |
2014 | 13.28M | 123.55% |
The current Enterprise Value of Purple Biotech Ltd. (PPBT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.76B
5-year avg
1.37B
10-year avg
4.31B
Purple Biotech Ltd.’s Enterprise Value is less than Pluri Inc. (47.77M), less than BioLineRx Ltd. (59.04M), less than Aridis Pharmaceuticals, Inc. (1.40M), less than Enlivex Therapeutics Ltd. (24.80M), less than Anebulo Pharmaceuticals, Inc. (45.92M), less than PMV Pharmaceuticals, Inc. (48.13M), less than Miromatrix Medical Inc. (90.06M), less than ZIVO Bioscience, Inc. (69.40M), greater than Bionomics Limited (-9094838.00), less than Bio-Path Holdings, Inc. (-340985.00), less than Endonovo Therapeutics, Inc. (7.37M), less than Cingulate Inc. (11.61M), less than Soleno Therapeutics, Inc. (2.13B), less than Cingulate Inc. (0), less than SAB Biotherapeutics, Inc. (11.61M), less than Cadrenal Therapeutics, Inc. Common Stock (25.39M), less than Monopar Therapeutics Inc. (10.21M), less than null (81.10M),
Company | Enterprise Value | Market cap |
---|---|---|
47.77M | $24.94M | |
59.04M | $37.41M | |
1.40M | $8.91K | |
24.80M | $27.83M | |
45.92M | $49.01M | |
48.13M | $84.49M | |
90.06M | $92.95M | |
69.40M | $68.83M | |
-9094838.00 | $3.41M | |
-340985.00 | $3.61M | |
7.37M | $350.63K | |
11.61M | $11.66M | |
2.13B | $2.18B | |
0 | $11.86M | |
11.61M | $37.29M | |
25.39M | $15.24M | |
10.21M | $87.22M | |
81.10M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Purple Biotech Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Purple Biotech Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Purple Biotech Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Purple Biotech Ltd. (PPBT)?
What is the 3-year average Enterprise Value for Purple Biotech Ltd. (PPBT)?
What is the 5-year average Enterprise Value for Purple Biotech Ltd. (PPBT)?
How does the current Enterprise Value for Purple Biotech Ltd. (PPBT) compare to its historical average?